Impact of transfusion strategy on platelet aggregation and biomarkers in myocardial infarction patients with anemia

Author:

Silvain Johanne1ORCID,Lattuca Benoit2ORCID,Puymirat Etienne3ORCID,Ducrocq Gregory4ORCID,Dillinger Jean-Guillaume5,Lhermusier Thibault6ORCID,Procopi Niki1ORCID,Cachanado Marine7ORCID,Drouet Elodie7ORCID,Abergel Helene4,Danchin Nicolas3,Montalescot Gilles1,Simon Tabassome7,Steg Philippe Gabriel48

Affiliation:

1. Sorbonne Université, ACTION Group, INSERM UMRS1166, Institut de Cardiologie , Hôpital Pitié-Salpêtrière (AP-HP), Paris 75013 , France

2. Cardiology Department, Nîmes University Hospital, Montpellier University , ACTION study group, Nîmes 30900 , France

3. Université Paris-Cité , AP-HP, Hôpital Européen Georges Pompidou, French Alliance for Cardiovascular Trials (FACT), Paris 75015 , France

4. Université Paris-Cité , AP-HP, French Alliance for Cardiovascular Trials (FACT), INSERM U1148, Paris 75018 , France

5. Department of Cardiology, Inserm U942, Hôpital Lariboisière, Assistance Publique - Hôpitaux de Paris, University Paris-Cité , Paris 75010 , France

6. CHU de Toulouse, Département de Cardiologie , Toulouse 31300 , France

7. Department of Clinical Pharmacology-Clinical Research Platform (URCEST-CRB-CRCEST), AP-HP, Hôpital Saint Antoine, French Alliance for Cardiovascular Trials (FACT), Sorbonne-Université , Paris 75012 , France

8. Institut Universitaire de France , Paris 75005 , France

Abstract

Abstract Background Higher rates of thrombotic events have been reported in myocardial infarction (MI) patients requiring blood transfusion. The impact of blood transfusion strategy on thrombosis and inflammation is still unknown. Objective To compare the impact of a liberal vs. a restrictive transfusion strategy on P2Y12 platelet reactivity and biomarkers in the multicentric randomized REALITY trial. Methods Patients randomized to a liberal (hemoglobin ≤10 g/dL) or a restrictive (hemoglobin ≤8 g/dL) transfusion strategy had VASP-PRI platelet reactivity measured centrally in a blinded fashion and platelet reactivity unit (PRU) measured locally using encrypted VerifyNow; at baseline and after randomization. Biomarkers of thrombosis (P-selectin, PAI-1, vWF) and inflammation (TNF-α) were also measured. The primary endpoint was the change in the VASP-PRI (difference from baseline and post randomization) between the randomized groups. Results A total of 100 patients randomized were included in this study (n = 50 in each group). Transfused patients received on average 2.4 ± 1.6 units of blood. We found no differences in change of the VASP PRI (difference 1.2% 95% CI (−10.3–12.7%)) or by the PRU (difference 13.0 95% CI (−21.8–47.8)) before and after randomization in both randomized groups. Similar results were found in transfused patients (n = 71) regardless of the randomized group, VASP PRI (difference 1.7%; 95% CI (−9.5–1.7%)) or PRU (difference 27.0; 95% CI (−45.0–0.0)). We did not find an impact of transfusion strategy or transfusion itself in the levels of P-selectin, PAI-1, vWF, and TNF-α. Conclusion In this study, we found no impact of a liberal vs. a restrictive transfusion strategy on platelet reactivity and biomarkers in MI patients with anemia. A conclusion that should be tempered due to missing patients with exploitable biological data that has affected our power to show a difference.

Funder

French Ministry of Health

ACTION Research Group

Institut National de la Santé et de la Recherche Médicale

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3